Leaflet RYMPHYSIA 500mg powder and solvent for solution for infusion
Product code: W68873001 Quantity: 1
Indicated for: alpha-1 antitrypsin deficiency
Route of administration: infusion
Substance: human alfa-1 proteinase inhibitor (alpha-1 proteinase inhibitor)
ATC: B02AB02 (Blood and blood forming organs | Antifibrinolytics | Proteinase inhibitors)
Human alpha-1 proteinase inhibitor is used for the treatment of alpha-1 antitrypsin deficiency, a genetic condition that can lead to lung diseases such as emphysema. It works by protecting lung tissue from enzymatic degradation.
The medication is administered intravenously, as directed by a doctor. It is important to monitor the patient for adverse reactions during the infusion.
Side effects may include headache, fever, dizziness, or injection site reactions. In rare cases, severe allergic reactions may occur.
This medication is not recommended for patients with hypersensitivity to human plasma proteins or severe IgA deficiency.
General data about RYMPHYSIA 500mg
- Substance: human alfa-1 proteinase inhibitor
- Date of latest medicines list: 01-07-2022
- Product code: W68873001
- Concentration: 500mg
- Pharmaceutical form: powder and solvent for solution for infusion
- Quantity: 1
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for human alfa-1 proteinase inhibitor
- 1000mg
- 500mg